Michael H. Davidson

Insider Reports History

Location
Princeton, NJ
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael H. Davidson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Chief Executive Officer, Director Ordinary Shares 390K $8.78M $22.49 26 Mar 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Executive Officer, Director Warrant (right to buy) 85K $978K $11.50 09 Oct 2024 Direct
CALADRIUS BIOSCIENCES, INC. Director Common Stock 210K $627K $2.99 10 Jan 2022 Direct
TENAX THERAPEUTICS, INC. Director Stock Option (right to buy) 80K $479K $5.99 01 Jul 2025 Direct
TENAX THERAPEUTICS, INC. Director Pre-Funded Warrant 47.5K $285K $5.99 01 Jul 2025 Direct
TENAX THERAPEUTICS, INC. Director Warrant 25K $150K $5.99 01 Jul 2025 Direct
TENAX THERAPEUTICS, INC. Director Common Stock 2.88K $17.3K $5.99 01 Jul 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Executive Officer, Director Option (right to buy) 670K 06 Jan 2025 Direct
Silence Therapeutics plc Director Share Option (Right to Buy) 48K 02 Jan 2025 Direct
BioAge Labs, Inc. Director Stock Option (Right to Buy) 22K 05 Jun 2025 Direct
Silence Therapeutics plc Director Ordinary Shares 13K 02 Jan 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Executive Officer, Director Restricted Stock Unit 0 26 Mar 2025 Direct

Insider Reports Filed by Michael H. Davidson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TENX TENAX THERAPEUTICS, INC. 01 Jul 2025 1 $0 4 Director 03 Jul 2025, 08:13
BIOA BioAge Labs, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:42
NAMS NewAmsterdam Pharma Co N.V. 26 Mar 2025 5 $0 4 Chief Executive Officer, Director 28 Mar 2025, 17:15
NAMS NewAmsterdam Pharma Co N.V. 06 Jan 2025 2 $0 4 Chief Executive Officer, Director 07 Jan 2025, 17:21
SLN Silence Therapeutics plc 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 0 $0 3 Director 02 Jan 2025, 16:34
TENX TENAX THERAPEUTICS, INC. 10 Dec 2024 1 $0 4 Director 12 Dec 2024, 19:54
NAMS NewAmsterdam Pharma Co N.V. 09 Oct 2024 1 -$173K 4 Chief Executive Officer, Director 11 Oct 2024, 17:01
BIOA BioAge Labs, Inc. 25 Sep 2024 0 $0 3 Director 25 Sep 2024, 16:51
NAMS NewAmsterdam Pharma Co N.V. 20 Aug 2024 1 $81.4K 4 Chief Executive Officer, Director 22 Aug 2024, 16:30
TENX TENAX THERAPEUTICS, INC. 08 Aug 2024 3 $0 4 Director 08 Aug 2024, 19:42
NAMS NewAmsterdam Pharma Co N.V. 20 Jun 2024 1 $86.3K 4 Chief Executive Officer, Director 24 Jun 2024, 08:30
BIOA BioAge Labs, Inc. 26 Mar 2024 2 $0 4 Director 27 Sep 2024, 16:20
NAMS NewAmsterdam Pharma Co N.V. 01 Jan 2024 1 $0 4 Chief Executive Officer, Director 03 Jan 2024, 17:14
NAMS NewAmsterdam Pharma Co N.V. 29 Dec 2023 0 $0 3/A Chief Executive Officer, Director 25 Jan 2024, 17:00
NAMS NewAmsterdam Pharma Co N.V. 29 Dec 2023 0 $0 3 Chief Executive Officer, Director 29 Dec 2023, 16:30
TENX TENAX THERAPEUTICS, INC. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 20:45
LSTA CALADRIUS BIOSCIENCES, INC. 10 Jan 2022 1 $0 4 Director 12 Jan 2022, 15:09
TENX TENAX THERAPEUTICS, INC. 11 Jun 2021 3 $0 4 Director 15 Jun 2021, 16:34
TENX TENAX THERAPEUTICS, INC. 25 Feb 2021 0 $0 3 Director 15 Jun 2021, 16:33